Showing results (171-180 of 626) with videos related to
Sort By:
Pageof 63
Neuropathology and Applied Neurobiology|October 27, 2001
Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degenerationI Ferrer, R Blanco, M Carmona, et al.Neuropathology and Applied Neurobiology|October 29, 2000
Fas and Fas-L expression in Huntington's disease and Parkinson's diseaseI Ferrer, R Blanco, B Cutillas, et al.Neuroscience|March 18, 2008
Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathiesG Muntané, E Dalfó, A Martinez, et al.Revista Espanola De Cardiologia|March 29, 2000
[The practical clinical guidelines of the Sociedad Española de Cardiología on interventional cardiology: coronary angioplasty and other technics]E Esplugas, F Alfonso, J J Alonso, et al.Neuroscience|June 8, 2000
Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob diseaseI Ferrer, B Puig, R Blanco, et al.Human Neurobiology|January 1, 1988
Decreased numbers of dendritic spines on cortical pyramidal neurons in dementia. A quantitative Golgi study on biopsy samplesI Catalá, I Ferrer, E Galofré, et al.Neuroscience|July 3, 1999
Bcl-2, Bax and Bcl-x expression following kainic acid administration at convulsant doses in the ratE López, E Pozas, R Rivera, et al.Revista De Neurologia|July 1, 1996
[Molecular factors of cerebral hypoxia-ischemia]A Macaya, F Munell, J Reventós, et al.Neurobiology of Disease|October 27, 2009
Involvement of Dab1 in APP processing and beta-amyloid deposition in sporadic Creutzfeldt-Jakob patientsR Gavín, I Ferrer, J A del RíoNeuroscience Letters|February 8, 2007
Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's diseaseI Ferrer, E Perez, E Dalfó, et al.Pageof 63